In November 2023, the UK became the first country in the world to authorise a Crispr gene-editing therapy.

After 35 years of consistent pain, Allan Byamukama became one of the few individuals in the world cured of sickle cell ...

The Sickle Cell Day Unit at the Royal London Hospital in Whitechapel, London, remains under threat following a temporary six-month trial, prompting sustained opposition from patients, families, and ...

When it was announced in 2023 that the world’s first Crispr-based gene-editing therapy had been approved in the UK there was ...

Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...

Learn about the global clinical trial for sickle cell disease aimed at improving quality of life and addressing anemia.

US based cooking expert Yewande Komolafe tells the story of her battle with sickle cell and recounts her journey back to ...

The United Kingdom's Medicines and Healthcare Products Regulatory Agency strengthened its warnings on GLP-1 receptor agonists ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance ...

DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...

Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.

The health number that matters more than cholesterol for stroke risk is Apolipoprotein B (ApoB), which is a blood marker that ...